Reno Vein Clinic is categorized under Internal Medicine Doctors in Reno, NV and active since 1999.
Reno Vein Clinic was established in 1999, and today employs 1 to 4, earning $2.500.000 to $4.999.999 per year. This is a Internal Medicine Doctors business, which does work in the B2C market, and is classified as a Internal Medicine Doctors, under code number 6214930 by the NAICS.
If you are seeking more information, feel free to contact Robert F Merchant Jr at the company’s single location by writing to 9480 Double Diamond Parkway # 100, Reno, Nevada NV 89521 or by phoning (775) 329-3100. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Reno Vein Clinic |
Contact Person: | Robert F Merchant Jr |
Address: | 9480 Double Diamond Parkway # 100, Reno, Nevada 89521 |
Phone Number: | (775) 329-3100 |
Website Address: | renoveinclinic.com |
Annual Revenue (USD): | $2.500.000 to $4.999.999 |
Founded: | 1999 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Internal Medicine Doctors |
SIC Code: | 8011 |
NAICS Code: | 6214930 |
Share This Business: |
Reno Vein Clinic was started in 1999 to provide professional Internal Medicine Doctors under the SIC code 8011 and NAICS code 6214930. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $2.500.000 to $4.999.999 per annum.
Feel free to contact Robert F Merchant Jr for inquiries that concern Reno Vein Clinic by calling the company number (775) 329-3100, as your correspondence is most welcome. Additionally, the physical location of the single location of Reno Vein Clinic can be found at the coordinates 39.44424,-119.74635 as well as the street address 9480 Double Diamond Parkway # 100 in Reno, Nevada 89521.
For its online presence, you may visit Reno Vein Clinic’s website at renoveinclinic.com and engage with its social media outlets through on Twitter and on Facebook.